Inflation Reduction Act may lower patients' Medicare costs for prostate cancer treatment
July 13th 2023"Within the Inflation Reduction Act, there is a provision that will cap the out-of-pocket contribution for Medicare beneficiaries, dropping to $3250 in 2024, as well as $2,000 in 2025," says Brian Cortese.
Expert: Availability of multiple PSMA agents “a boon” for patients
July 6th 2023“I think the prostate cancer community has benefited a lot in the past several years with the advent of enhanced imaging tools to help us better stage patients with prostate cancer both at their initial diagnosis and if, unfortunately, they have a recurrence,” says Edward M. Schaeffer, MD, PhD.
Dr. Conor Driscoll on the effect of TNF alpha inhibitor use on prostate cancer risk
July 4th 2023"I would say that the take-home message of the study is that these immunosuppressive medications have alterations in the microbiology in a lot of these organs and a lot of these tumors," says Conor Driscoll, MD.
Long-term TNF alpha inhibitor use linked with decreased risk of prostate cancer
June 30th 2023"Prostate cancer showed a decreased risk, which we thought was very interesting, because it was the only cancer for which that signal existed, that there is possibly a protective effect of these medications," says Conor Driscoll, MD.